| Literature DB >> 35919183 |
Yanming Miao1, Xinhao Zhang1, Jinyao Li1, Wenli Yang1, Xiaomin Huang1, Jinzhi Lv1.
Abstract
Room-temperature phosphorescent (RTP) N-doped carbon-dots (CNDs) featuring eco-friendliness, low cost and high biocompatibility, are ideal photodynamic antibacterial and anticancer nanomaterials. However, the existing CNDs are limited by low singlet oxygen (1O2) quantum yield, which has become a bottleneck in the development of CNDs. One basic reason is the short T1-state exciton lifetime of CNDs. Herein, triethylenetetramine hexaacetic acid was used to synthesize CNDs via a one-step hydrothermal method. CNDs are characterized with low toxicity, high biocompatibility and ultralong-lifetime RTP (URTP). In addition to the URTP (average lifetime 414 ms) under solid conditions, CNDs even had URTP (average lifetime 320 ms) in a water environment. The ultralong T1 exciton lifetime largely extends the collision time between T1 state excitons and O2 and prolongs the energy transfer time, not only improving the quantum yield (0.63) of singlet oxygen (1O2) in solution, but also facilitating the photodynamic antibacterial and anticancer effects. This journal is © The Royal Society of Chemistry.Entities:
Year: 2022 PMID: 35919183 PMCID: PMC9285010 DOI: 10.1039/d2ra02251f
Source DB: PubMed Journal: RSC Adv ISSN: 2046-2069 Impact factor: 4.036
Fig. 1Schematic diagram of the preparation of CNDs.
Fig. 2Characterization of CNDs: (A) TEM image of CNDs (inset: particle size distribution); (B) XRD pattern of CNDs; (C) XPS spectrum of CNDs; (D) C 1s, (E) O 1s and (F) N 1s high-resolution spectra; (G) infrared spectrum of CNDs.
Fig. 3URTP spectral properties of CNDs. (A) 3D URTP spectrum of CNDs; (B) URTP spectra of CNDs under excitation at 325 and 365 nm (inset: irradiation photos when a 365 nm light source is opened or closed); (C) URTP lifetime of CNDs; (D) UV absorption and URTP emission spectra of CNDs in aqueous solution; (E) URTP lifetime of CNDs in aqueous solution; (F) the URTP intensity of CNDs in aqueous solution changed under non-deoxygenating (top) and deoxygenating (bottom) conditions; (G) absorption spectrum of TMB under irradiation with ultraviolet light with CNDs (10 mg mL−1) and time; (H) EPR spectrum of CNDs in the presence of TEMP (TEMP is a special spin trap for 1O2, irradiation time with a 365 nm LED = 60 s, 10 mg mL−1 CNDs); (I) effects of CNDs and PB on UV-vis spectra of DPBF under excitation at 365 nm; (J) fluorescence and phosphorescence of CNDs, and energy transfer from O2 to 1O2.
Fig. 4(A) The effect of different concentrations of CNDs (0 and 5 μg mL−1) on bacteria under light/non-light conditions; the number (estimate) of colonies under different conditions: (B) Bacillus subtilis and (C) Escherichia coli.
Fig. 5Effects of CNDs on the activity of HeLa cells in vitro: measurement by the MTT method. (A) Effects of CND concentration (0, 2, 200, 2000, 5000, 10 000 μg mL−1) on the activity of HeLa cells (30 min of irradiation); (B) effects of irradiation time (0, 1, 5, 10, 30, 60 min) on the activity of HeLa cells (CND concentration = 200 μg mL−1); (C) effects of irradiation time (0, 1, 5, 10, 30 min) alone (without CNDs) on the activity of HeLa cells; (D) laser confocal microscopic images of HeLa cells incubated with (left) Cy3.5 or (right) Cy3.5-marked CNDs for 1, 4, 8, 16, 24, and 48 h, cell microfilaments (MF) dyed with phalloidin (green), nuclei dyed with DAPI (blue), scale at 20 μm; (E) calcein-AM/PI staining images after processing with PBS (phosphate buffer solution) and CNDs + irradiation, dead cells (red), living cells (green), scale = 100 μm; (F) generation of intracellular 1O2 after processing with DCFH-DA-marked PBS and CNDs + irradiation, scale = 100 μm; (G) effects of PBS and CNDs + irradiation on cellular 1O2; (H) effects of PBS and CNDs + irradiation on cell apoptosis (ratio of apoptotic cells %); (I) photodynamic anti-HeLa cancer cell process based on CND URTP.
Fig. 6Therapeutic effects of CNDs on tumors in vivo. (A) Images of mice and tumors at 16 days after in vivo tumor treatment with PBS and CNDs + LED (upper); tissue staining (H&E) in tumor, heart, liver, spleen, lung and kidney sections (lower) at 16 days after treatment of intraneous tumors with PBS or CNDs + LED, scale = 50 μm; (B) tumor growth curves of mice after PBS or CNDs + LED treatment; (C) schematic diagram of CNDs inhibiting cancer cells.